[(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid

C29H36BF2NO3 — CID 68805932

IUPAC[(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid
SMILESC[C@]12CC[C@@H]3c4ccc(B(O)O)cc4CC[C@H]3[C@@H]1[C@@H](CCCC(=O)NCc1ccccc1)CC2(F)F
InChIInChI=1S/C29H36BF2NO3/c1-28-15-14-24-23-13-11-22(30(35)36)16-20(23)10-12-25(24)27(28)21(17-29(28,31)32)8-5-9-26(34)33-18-19-6-3-2-4-7-19/h2-4,6-7,11,13,16,21,24-25,27,35-36H,5,8-10,12,14-15,17-18H2,1H3,(H,33,34)/t21-,24+,25+,27-,28-/m0/s1
InChIKeyIJQJVCPMLXHLBZ-PVNFNAHNSA-N
MW495.42 g/mol
LogP4.57
Rot. Bonds7

About [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid

[(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid (PubChem CID 68805932) has the molecular formula C29H36BF2NO3 and a molecular weight of 495.42 g/mol. Its IUPAC name is [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid.

Molecular Properties

Compound Name[(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid
PubChem CID68805932
Molecular FormulaC29H36BF2NO3
Molecular Weight495.42 g/mol
Exact Mass495.28
IUPAC Name[(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid
SMILESC[C@]12CC[C@@H]3c4ccc(B(O)O)cc4CC[C@H]3[C@@H]1[C@@H](CCCC(=O)NCc1ccccc1)CC2(F)F
InChIInChI=1S/C29H36BF2NO3/c1-28-15-14-24-23-13-11-22(30(35)36)16-20(23)10-12-25(24)27(28)21(17-29(28,31)32)8-5-9-26(34)33-18-19-6-3-2-4-7-19/h2-4,6-7,11,13,16,21,24-25,27,35-36H,5,8-10,12,14-15,17-18H2,1H3,(H,33,34)/t21-,24+,25+,27-,28-/m0/s1
InChIKeyIJQJVCPMLXHLBZ-PVNFNAHNSA-N
XLogP4.57
TPSA69.56 Ų
H-Bond Donors3
H-Bond Acceptors3
Rotatable Bonds7
Heavy Atoms36
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500495.42
LogP ≤ 54.57
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Fce 28260
CID 132992
Pnu-157706
CID 9915313
(1R,5R,9S,13S)-5,9,13-trimethyl-N-[(4-methylphenyl)methyl]-14-oxotetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxamide
CID 42601336
(1R,5R,9S,13S)-N-benzyl-5,9,13-trimethyl-14-oxotetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxamide
CID 42601330
(1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-N-benzyl-5a,5b,8,8,11a-pentamethyl-9-oxo-1-prop-1-en-2-yl-2,3,4,5,6,7,7a,10,11,11b,12,13,13a,13b-tetradecahydro-1H-cyclopenta[a]chrysene-3a-carboxamide
CID 127041995
(4R)-4-[(3R,3aR,5aS,6R,9aS,9bS)-6-[3-(benzylamino)-3-oxopropyl]-3a,6-dimethyl-7-prop-1-en-2-yl-2,3,4,5,5a,7,8,9,9a,9b-decahydro-1H-cyclopenta[a]naphthalen-3-yl]-N-benzylpentanamide
CID 134146783
N-[3,3,3-trifluoro-1-[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]propyl]acetamide
CID 135022570
(4R)-4-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-azido-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-N-benzylpentanamide
CID 73057971
N-[[4-fluoro-3-(trifluoromethyl)phenyl]methyl]spiro[cyclopropane-2,9'-fluorene]-1-carboxamide
CID 132460352
(1S,3aS,5aR,9aS,11aS)-8-fluoro-N-[(2-fluorophenyl)methyl]-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide
CID 9955711
(8S,9S,10R,13S,14S,17S)-N-(1,1,1,3,3,3-hexafluoro-2-phenylpropan-2-yl)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxamide
CID 9958979
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[(4-fluorophenyl)methyl]-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide
CID 10114055

Frequently Asked Questions

What is the IUPAC name of [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid?
The IUPAC name of [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid (CID 68805932) is [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid.
What is the SMILES notation for [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid?
The canonical SMILES for [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid is C[C@]12CC[C@@H]3c4ccc(B(O)O)cc4CC[C@H]3[C@@H]1[C@@H](CCCC(=O)NCc1ccccc1)CC2(F)F.
What is the InChIKey of [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid?
The InChIKey is IJQJVCPMLXHLBZ-PVNFNAHNSA-N. The full InChI is InChI=1S/C29H36BF2NO3/c1-28-15-14-24-23-13-11-22(30(35)36)16-20(23)10-12-25(24)27(28)21(17-29(28,31)32)8-5-9-26(34)33-18-19-6-3-2-4-7-19/h2-4,6-7,11,13,16,21,24-25,27,35-36H,5,8-10,12,14-15,17-18H2,1H3,(H,33,34)/t21-,24+,25+,27-,28-/m0/s1.
What are the key properties of [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid?
[(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid has a molecular weight of 495.42 g/mol, XLogP of 4.57, 7 rotatable bonds, 3 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for [(8R,9S,13S,14S,15S)-15-[4-(benzylamino)-4-oxobutyl]-17,17-difluoro-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]boronic acid is sourced from PubChem (CID 68805932), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).